234 related articles for article (PubMed ID: 25197413)
21. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
[TBL] [Abstract][Full Text] [Related]
22. Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma.
Matsuo K; Ross MS; Bush SH; Yunokawa M; Blake EA; Takano T; Ueda Y; Baba T; Satoh S; Shida M; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Takeuchi S; Nishimura M; Iwasaki K; Yanai S; Klobocista MM; Johnson MS; Machida H; Hasegawa K; Miyake TM; Nagano T; Pejovic T; Shahzad MM; Im DD; Omatsu K; Ueland FR; Kelley JL; Roman LD
Gynecol Oncol; 2017 Feb; 144(2):329-335. PubMed ID: 27931750
[TBL] [Abstract][Full Text] [Related]
23. Development of uterine sarcoma after tamoxifen treatment for breast cancer: report of four cases.
Yildirim Y; Inal MM; Sanci M; Yildirim YK; Mit T; Polat M; Tinar S
Int J Gynecol Cancer; 2005; 15(6):1239-42. PubMed ID: 16343223
[TBL] [Abstract][Full Text] [Related]
24. Uterine malignant mixed müllerian tumor in a patient on long-term tamoxifen therapy for breast cancer.
Clarke MR
Gynecol Oncol; 1993 Dec; 51(3):411-5. PubMed ID: 8112655
[TBL] [Abstract][Full Text] [Related]
25. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
[TBL] [Abstract][Full Text] [Related]
26. Uterine sarcomas in breast cancer patients treated with tamoxifen.
Arenas M; Rovirosa A; Hernández V; Ordi J; Jorcano S; Mellado B; Biete A
Int J Gynecol Cancer; 2006; 16(2):861-5. PubMed ID: 16681774
[TBL] [Abstract][Full Text] [Related]
27. Primary carcinosarcoma of the vagina.
Shibata R; Umezawa A; Takehara K; Aoki D; Nozawa S; Hata J
Pathol Int; 2003 Feb; 53(2):106-10. PubMed ID: 12588439
[TBL] [Abstract][Full Text] [Related]
28. Papillary-serous adenocarcinoma of the uterine cervix during tamoxifen therapy after bilateral breast cancer.
Watrowski R; Striepecke E; Jäger C; Bauknecht T; Horst C
Anticancer Res; 2012 Nov; 32(11):5075-8. PubMed ID: 23155282
[TBL] [Abstract][Full Text] [Related]
29. Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen.
Silva EG; Tornos CS; Follen-Mitchell M
Int J Gynecol Pathol; 1994 Jul; 13(3):248-58. PubMed ID: 7928058
[TBL] [Abstract][Full Text] [Related]
30. A breast cancer patient with pelvic and gastric malignancy after adjuvant tamoxifen treatment for breast cancer.
Dede M; Gezginç K; Ulubay M; Alanbay I; Güran S; Yenen M
Eur J Gynaecol Oncol; 2008; 29(2):200. PubMed ID: 18459568
[TBL] [Abstract][Full Text] [Related]
31. Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature.
Meguro S; Yasuda M; Shimizu M; Kurosaki A; Fujiwara K
Diagn Pathol; 2013 May; 8():74. PubMed ID: 23651629
[TBL] [Abstract][Full Text] [Related]
32. Tamoxifen related Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT): A case report and literature review of this possible association.
Segala D; Gobbo S; Pesci A; Martignoni G; Santoro A; Angelico G; Arciuolo D; Spadola S; Valente M; Scambia G; Zannoni GF
Pathol Res Pract; 2019 May; 215(5):1089-1092. PubMed ID: 30799070
[TBL] [Abstract][Full Text] [Related]
33. Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: a comparative study in 363 patients.
Ngô C; Brugier C; Plancher C; de la Rochefordière A; Alran S; Féron JG; Malhaire C; Scholl S; Sastre X; Rouzier R; Fourchotte V;
Eur J Surg Oncol; 2014 Oct; 40(10):1237-44. PubMed ID: 25086993
[TBL] [Abstract][Full Text] [Related]
34. Carcinosarcoma of the uterus in advanced stage: a case report.
Tasic L; Vasiljevic M; Prorocic M; Jurisic A; Dragojevic-Dikic S; Jankovic-Raznatovic S
Eur J Gynaecol Oncol; 2013; 34(4):343-6. PubMed ID: 24020144
[TBL] [Abstract][Full Text] [Related]
35. Primary uterine rhabdomyosarcoma in a patient with a history of breast cancer and gastrointestinal stromal tumor.
Gottwald L; Gora E; Korczynski J; Piekarski JH; Morawiec Z; Jesionek-Kupnicka D; Sowa P; Cialkowska-Rysz A; Bienkiewicz A
J Obstet Gynaecol Res; 2008 Aug; 34(4 Pt 2):721-5. PubMed ID: 18840190
[TBL] [Abstract][Full Text] [Related]
36. [Primary ovarian malignant mixed mesodermal tumor (MMMT) as a second primary tumor in a patient with invasive breast carcinoma--case report].
Sentija K; Bolanca IK; Simon SK; Kukura V; Skrtić A; Gasparov S
Acta Med Croatica; 2011 Sep; 65 Suppl 1():229-34. PubMed ID: 23126058
[TBL] [Abstract][Full Text] [Related]
37. Mullerian adenosarcoma of the uterus associated with tamoxifen therapy.
Arici DS; Aker H; Yildiz E; Tasyurt A
Arch Gynecol Obstet; 2000 Sep; 264(2):105-7. PubMed ID: 11045336
[TBL] [Abstract][Full Text] [Related]
38. High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.
Magriples U; Naftolin F; Schwartz PE; Carcangiu ML
J Clin Oncol; 1993 Mar; 11(3):485-90. PubMed ID: 8383191
[TBL] [Abstract][Full Text] [Related]
39. The uterine carcinosarcoma - a case report.
Niculescu M; Simionescu C; Novac L; Mogoantă L; Stănescu RM
Rom J Morphol Embryol; 2007; 48(4):431-5. PubMed ID: 18060197
[TBL] [Abstract][Full Text] [Related]
40. Is there any association between uterine malignant mixed Mullerian tumour, breast cancer and prolonged tamoxifen treatment?
Moe MM; El-Sharkawi S
J Obstet Gynaecol; 2003 May; 23(3):301-3. PubMed ID: 12850867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
